Docetaxel weekly with metastatic breast cancer

被引：6
|
作者：
Twelves, Chris [1 ]
机构：
[1] St James Univ Hosp, Canc Res UK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England
来源：
ONKOLOGIE | 2007年 / 30卷 / 8-9期
关键词：
D O I：
10.1159/000106841
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：407 / 408
页数：2
相关论文
共 50 条
  • [21] A phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.
    Grecea, D
    Tanasescu, R
    Vasiliniuc, C
    Neamtiu, L
    Ghilezan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 62S - 62S
  • [22] Weekly vinorelbine versus docetaxel for metastatic breast cancer after failing anthracycline treatment
    Meier, Carl Richard
    Illiger, Hans-Jochen
    Steder, Martin
    Janssen, Jan
    Deertz, Holger
    Braun, Manfred
    Oeney, Hueseyin-Taylan
    Deuss, Burkhard
    Kuechler, Thomas
    Rotermund, Susanne
    ONKOLOGIE, 2008, 31 (8-9): : 447 - 453
  • [23] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Hugo E. R. Ford
    Yoon-Sim Yap
    David W. Miles
    Andreas Makris
    Marcia Hall
    Liz Miller
    Mark Harries
    Ian E. Smith
    Stephen R. D. Johnston
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 809 - 815
  • [24] Phase II pilot results of imatinib mesylate with weekly docetaxel in metastatic breast cancer
    Waterhouse, D. M.
    Mainwaring, M.
    Barton, J.
    Webb, C.
    Markus, T. M.
    Spigel, D. R.
    Infante, J. R.
    Hainsworth, J. D.
    Greco, F. A.
    Yardley, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Ford, Hugo E. R.
    Yap, Yoon-Sim
    Miles, David W.
    Makris, Andreas
    Hall, Marcia
    Miller, Liz
    Harries, Mark
    Smith, Ian E.
    Johnston, Stephen R. D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (06) : 809 - 815
  • [26] Metastatic breast cancer with resistance to both anthracycline and docetaxel successfully treated with weekly paclitaxel
    Ishitobi M.
    Shin E.
    Kikkawa N.
    International Journal of Clinical Oncology, 2001, 6 (1) : 55 - 58
  • [27] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    T Gamucci
    A M D'Ottavio
    E Magnolfi
    M Barduagni
    A Vaccaro
    I Sperduti
    L Moscetti
    F Belli
    L Meliffi
    British Journal of Cancer, 2007, 97 : 1040 - 1045
  • [28] Weekly combination of docetaxel and vinorelbine in metastatic breast cancer: A phase I/II study
    Cals, L
    Nouyrigat, P
    Valenza, B
    Pedinelli, FJ
    Juin, P
    ONCOLOGY, 2004, 67 (3-4) : 257 - 261
  • [29] Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients
    Ramaswamy, Bhuvaneswari
    Elias, Anthony D.
    Kelbick, Nicole T.
    Dodley, Angela
    Morrow, Mark
    Hauger, Marsha
    Allen, Joan
    Rhoades, Chris
    Kendra, Kari
    Chen, Helen X.
    Eckhardt, S. Gail
    Shapiro, Charles L.
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3124 - 3129
  • [30] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    Gamucci, T.
    D'Ottavio, A. M.
    Magnolfi, E.
    Barduagni, M.
    Vaccaro, A.
    Sperduti, I.
    Moscetti, L.
    Belli, F.
    Meliffi, L.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1040 - 1045
12345